The gut microbiome composition of breast cancer patients differs based on their estrogen receptor (ER) status, with patients with ER‐positive breast cancer having a higher abundance of Lactobacillus and Bifidobacterium, while patients with ER‐negative breast cancer had a higher abundance of Fusobacterium.66 The gene discussed is ESR1; the disease is breast cancer.